Mesenchymal stem cells transplanted into spinal cord injury adopt immune cell-like characteristics

[1]  C. Liang,et al.  Strategies and prospects of effective neural circuits reconstruction after spinal cord injury , 2020, Cell Death & Disease.

[2]  Michael R Hamblin,et al.  Differentiation of Mesenchymal Stem Cells to Neuroglia: in the Context of Cell Signalling , 2019, Stem Cell Reviews and Reports.

[3]  A. Vercelli,et al.  Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy , 2019, International journal of molecular sciences.

[4]  G. Constantin,et al.  Nanovesicles from adipose-derived mesenchymal stem cells inhibit T lymphocyte trafficking and ameliorate chronic experimental autoimmune encephalomyelitis , 2018, Scientific Reports.

[5]  Ronghu Wu,et al.  Extracellular vesicles from bone marrow-derived mesenchymal stromal cells support ex vivo survival of human antibody secreting cells , 2018, Journal of extracellular vesicles.

[6]  Jee-Yin Ahn,et al.  Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung injury , 2018, Experimental & Molecular Medicine.

[7]  K. Costa,et al.  Exosomal microRNA-21-5p Mediates Mesenchymal Stem Cell Paracrine Effects on Human Cardiac Tissue Contractility , 2018, Circulation research.

[8]  K. C. Nam,et al.  A Novel Secretory Vesicle from Deer Antlerogenic Mesenchymal Stem Cell-Conditioned Media (DaMSC-CM) Promotes Tissue Regeneration , 2018, Stem cells international.

[9]  Ashok Kumar,et al.  Mesenchymal stromal cell-derived exosome-rich fractionated secretome confers a hepatoprotective effect in liver injury , 2018, Stem Cell Research & Therapy.

[10]  L. Slovinská,et al.  The neuroprotective effect of rat adipose tissue-derived mesenchymal stem cell-conditioned medium on cortical neurons using an in vitro model of SCI inflammation , 2018, Neurological research.

[11]  C. Cox,et al.  Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Modify Microglial Response and Improve Clinical Outcomes in Experimental Spinal Cord Injury , 2018, Scientific Reports.

[12]  J. Vykoukal,et al.  Inflammation‐Stimulated Mesenchymal Stromal Cell‐Derived Extracellular Vesicles Attenuate Inflammation , 2018, Stem cells.

[13]  Yu Li,et al.  Human adipose-derived mesenchymal stem cell-conditioned media suppresses inflammatory bone loss in a lipopolysaccharide-induced murine model , 2017, Experimental and therapeutic medicine.

[14]  J. López,et al.  Exosomes promote restoration after an experimental animal model of intracerebral hemorrhage , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  A. Curt,et al.  Traumatic spinal cord injury , 2017, Nature Reviews Disease Primers.

[16]  L. Lerman,et al.  Integrated transcriptomic and proteomic analysis of the molecular cargo of extracellular vesicles derived from porcine adipose tissue-derived mesenchymal stem cells , 2017, PloS one.

[17]  M. Nishi,et al.  Bone marrow stromal cell sheets may promote axonal regeneration and functional recovery with suppression of glial scar formation after spinal cord transection injury in rats. , 2017, Journal of neurosurgery. Spine.

[18]  L. Lerman,et al.  Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair. , 2017, Current gene therapy.

[19]  J. Kocsis,et al.  Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury , 2016, Neuroscience.

[20]  Fábio Gonçalves Teixeira,et al.  MSCs-Derived Exosomes: Cell-Secreted Nanovesicles with Regenerative Potential , 2016, Front. Pharmacol..

[21]  Zhong-jie Yan,et al.  Transplantation of Human Amniotic Mesenchymal Stem Cells Promotes Functional Recovery in a Rat Model of Traumatic Spinal Cord Injury , 2016, Neurochemical Research.

[22]  Jae-Hoon Lee,et al.  Expression of neurotrophic factors in injured spinal cord after transplantation of human-umbilical cord blood stem cells in rats , 2016, Journal of veterinary science.

[23]  Yuming Zhao,et al.  Profiling the Secretome of Human Stem Cells from Dental Apical Papilla. , 2016, Stem cells and development.

[24]  Qi Hao,et al.  Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice. , 2015, American journal of respiratory and critical care medicine.

[25]  Liping Liu,et al.  Spinal cord injury in rats treated using bone marrow mesenchymal stem-cell transplantation. , 2015, International journal of clinical and experimental medicine.

[26]  J. Kocsis,et al.  Diffuse and persistent blood–spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells , 2015, Experimental Neurology.

[27]  X. Navarro,et al.  Immunosuppression of allogenic mesenchymal stem cells transplantation after spinal cord injury improves graft survival and beneficial outcomes. , 2015, Journal of neurotrauma.

[28]  R. B. Richardson,et al.  A Systematic Review of Preclinical Studies on the Therapeutic Potential of Mesenchymal Stromal Cell-Derived Microvesicles , 2015, Stem Cell Reviews and Reports.

[29]  Bo Yang,et al.  Human umbilical cord blood-derived mesenchymal stem cell transplantation for the treatment of spinal cord injury , 2014, Experimental and therapeutic medicine.

[30]  Y. Taura,et al.  Canine Bone Marrow Stromal Cells Promote Functional Recovery in Mice with Spinal Cord Injury , 2014, The Journal of veterinary medical science.

[31]  K. Martin,et al.  Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome. , 2014, Brain : a journal of neurology.

[32]  K. Ha,et al.  Bone Marrow–Derived Mesenchymal Stem Cell Transplantation for Chronic Spinal Cord Injury in Rats: Comparative Study Between Intralesional and Intravenous Transplantation , 2013, Spine.

[33]  Zhilai Zhou,et al.  Comparison of mesenchymal stromal cells from human bone marrow and adipose tissue for the treatment of spinal cord injury. , 2013, Cytotherapy.

[34]  K. Ha,et al.  Fate of Transplanted Bone Marrow Derived Mesenchymal Stem Cells Following Spinal Cord Injury in Rats by Transplantation Routes , 2012, Journal of Korean medical science.

[35]  S. Totey,et al.  Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury. , 2010, Cytotherapy.

[36]  Luca Sterpone,et al.  Microvesicles Derived from Adult Human Bone Marrow and Tissue Specific Mesenchymal Stem Cells Shuttle Selected Pattern of miRNAs , 2010, PloS one.

[37]  Buwei Yu,et al.  Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord , 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.

[38]  E. Woo,et al.  A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury , 2009, Journal of the Neurological Sciences.

[39]  K. Meade,et al.  Tumour necrosis factor-alpha (TNF-alpha) increases nuclear factor kappaB (NFkappaB) activity in and interleukin-8 (IL-8) release from bovine mammary epithelial cells. , 2007, Veterinary immunology and immunopathology.

[40]  Wolfram Tetzlaff,et al.  Contusion, dislocation, and distraction: primary hemorrhage and membrane permeability in distinct mechanisms of spinal cord injury. , 2007, Journal of neurosurgery. Spine.

[41]  Ján Rosocha,et al.  Transplants of Human Mesenchymal Stem Cells Improve Functional Recovery After Spinal Cord Injury in the Rat , 2006, Cellular and Molecular Neurobiology.

[42]  O. Ringdén,et al.  HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. , 2003, Experimental hematology.

[43]  R. Abraham,et al.  Tyrosine phosphorylation‐dependent activation of NF‐κB , 2001 .

[44]  G. Haegeman,et al.  Effects of antioxidant enzyme modulations on interleukin-1-induced nuclear factor kappa B activation. , 1997, Biochemical pharmacology.

[45]  T. Mitamura,et al.  Heparin‐binding EGF‐like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up‐regulates functional receptors and diphtheria toxin sensitivity. , 1994, The EMBO journal.

[46]  D. Russell,et al.  Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor , 1992, Cell.

[47]  M. Ericsson,et al.  Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation , 2018, American journal of respiratory and critical care medicine.

[48]  M. Pittenger,et al.  Unraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects. , 2016, Transfusion medicine reviews.

[49]  Siddaraju Boregowda,et al.  Isolation of Mouse Bone Marrow Mesenchymal Stem Cells. , 2016, Methods in molecular biology.

[50]  G. Duruksu,et al.  The Effects of Adipose Tissue-Derived Mesenchymal Stem Cell Transplantation During the Acute and Subacute Phases Following Spinal Cord Injury. , 2016, Turkish neurosurgery.

[51]  B. S. Ramalho,et al.  Chronic spinal cord lesions respond positively to tranplants of mesenchymal stem cells. , 2015, Restorative neurology and neuroscience.

[52]  G. Duruksu,et al.  Reduction of lesion in injured rat spinal cord and partial functional recovery of motility after bone marrow derived mesenchymal stem cell transplantation. , 2012, Turkish neurosurgery.

[53]  D. Yoon,et al.  Human mesenchymal stem cell transplantation promotes functional recovery following acute spinal cord injury in rats. , 2007, Acta neurobiologiae experimentalis.

[54]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[55]  R. Abraham,et al.  Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases. , 2001, European journal of biochemistry.